TABLE 2

Tracer-determined rates of Rd and EGP during steady-state conditions (270–330 min) of AA and saline infusion

AAControl
Rd (μmol·kg−1·min−1)47.3 ± 4.4*60.0 ± 2.6
EGP (μmol·kg−1·min−1)−0.7 ± 0.9−1.6 ± 1.0
  • Data are given means ± SE of seven healthy subjects who underwent both somatostatin insulin glucagon growth hormone clamp tests.

  • *

    * P < 0.01 vs. saline infusion.